Research Reports

Key takeaways

Jason Richardson appointed as Executive Vice President, Chief Financial Officer and Treasurer, effective April 6, 2026.

Michael Bourque will step down as CFO on the same date and remain as a Senior Advisor providing transition services through June 30, 2026.

Richardson's compensation includes a $525,000 annual base salary and a target annual bonus of 70% of base salary.

He will receive equity awards of 200,000 restricted stock units, split equally between time-based and performance-based awards.

The appointment is part of leadership changes designed to accelerate the company's next phase of growth.

Full analysis

Inogen has appointed Jason Richardson as its new Chief Financial Officer, bringing extensive financial leadership experience from Baxter International and Hillrom, particularly in the respiratory care segment. This executive transition marks a strategic leadership change as the company aims to accelerate its next phase of growth. Richardson's compensation package includes significant equity incentives tied to both time-based and performance-based vesting, aligning his interests with long-term shareholder value creation. The structured transition with outgoing CFO Michael Bourque remaining as Senior Advisor through June 30, 2026, ensures continuity and knowledge transfer. The company's press release indicates these leadership appointments are designed to strengthen Inogen's position in the respiratory care market and support its innovation pipeline, including the goal of launching at least one new product per year.

INGN · Inogen, Inc.

Summary

Key takeaways

Full analysis